TORONTO, June 1, 2012 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN.TO - News), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced a poster presentation based on an abstract entitled “Blood signatures for early liver cancer detection in patients with chronic hepatitis B” at the annual meeting of the American Society of Clinical Oncology (“ASCO”), being held at McCormick Place in Chicago, IL from June 1-5, 2012.
